AGT and kidney disorder: Nevertheless, this also poses a threat in situations where the RAS is acutely needed, and thus preclinical and clinical programs are now carefully investigating its efficacy and safety profile, allowing an optimal introduction of AGT suppression as a novel treatment of cardiovascular and renal diseases in due time.